THC Biomed Intl Ltd
THC Biomed Intl Ltd. engages in the research, development, production, and sale of cannabis products in Canada. The company offers cannabis consumables, including beverage drinks, gummies, baked goods, pre-rolls, sticks, and clones under the THC Kiss brand name; and genetic strains under the THC BioMed brand name. It also provides dry flowers under the Smoke That Thunders brand name; buds under t… Read more
Market Cap & Net Worth: THC Biomed Intl Ltd (THCBF)
THC Biomed Intl Ltd (PINK:THCBF) has a market capitalization of $163.94K ($163.94K) as of March 19, 2026. Listed on the PINK stock exchange, this USA-based company holds position #40663 globally and #13188 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying THC Biomed Intl Ltd's stock price $0.00 by its total outstanding shares 163938556 (163.94 Million).
THC Biomed Intl Ltd Market Cap History: 2015 to 2025
THC Biomed Intl Ltd's market capitalization history from 2015 to 2025. Data shows change from $11.64 Million to $163.94K (-34.95% CAGR).
THC Biomed Intl Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how THC Biomed Intl Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.27x
THC Biomed Intl Ltd's market cap is 1.27 times its annual revenue
1.02x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $120.49 Million | $500.00K | -$286.34K | 240.99x | N/A |
| 2017 | $127.36 Million | $59.88K | -$604.87K | 2127.13x | N/A |
| 2018 | $39.44 Million | $925.34K | -$12.46 Million | 42.63x | N/A |
| 2019 | $19.57 Million | $1.49 Million | -$12.70 Million | 13.14x | N/A |
| 2020 | $12.13 Million | $4.18 Million | -$161.59K | 2.90x | N/A |
| 2021 | $9.67 Million | $3.77 Million | -$6.36 Million | 2.56x | N/A |
| 2022 | $3.11 Million | $2.45 Million | -$3.07 Million | 1.27x | N/A |
Competitor Companies of THCBF by Market Capitalization
Companies near THC Biomed Intl Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to THC Biomed Intl Ltd by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
THC Biomed Intl Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, THC Biomed Intl Ltd's market cap moved from $11.64 Million to $ 163.94K, with a yearly change of -34.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $163.94K | 0.00% |
| 2024 | $163.94K | -93.33% |
| 2023 | $2.46 Million | -21.05% |
| 2022 | $3.11 Million | -67.80% |
| 2021 | $9.67 Million | -20.27% |
| 2020 | $12.13 Million | -38.02% |
| 2019 | $19.57 Million | -50.37% |
| 2018 | $39.44 Million | -69.03% |
| 2017 | $127.36 Million | +5.70% |
| 2016 | $120.49 Million | +935.21% |
| 2015 | $11.64 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of THC Biomed Intl Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $163.94K USD |
| MoneyControl | $163.94K USD |
| MarketWatch | $163.94K USD |
| marketcap.company | $163.94K USD |
| Reuters | $163.94K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.